Index -
P/E -
EPS (ttm) -4.53
Insider Own 47.17%
Shs Outstand 2.08M
Perf Week 3.76%
Market Cap 49.31M
Forward P/E -
EPS next Y -
Insider Trans 0.33%
Shs Float 1.38M
Perf Month 5.89%
Income -18.31M
PEG -
EPS next Q -
Inst Own 12.84%
Short Float 2.09%
Perf Quarter -6.02%
Sales 1.00M
P/S 49.31
EPS this Y -
Inst Trans 9.04%
Short Ratio 1.00
Perf Half Y -45.20%
Book/sh 5.75
P/B 2.69
EPS next Y -
ROA -63.03%
Short Interest 0.03M
Perf Year 6.74%
Cash/sh 13.03
P/C 1.19
EPS next 5Y -
ROE -2570.57%
52W Range 7.38 - 30.99
Perf YTD 34.43%
Dividend Est. -
P/FCF -
EPS past 5Y 18.96%
ROI -121.72%
52W High -50.11%
Beta 0.65
Dividend TTM -
Quick Ratio 6.69
Sales past 5Y -26.58%
Gross Margin 91.00%
52W Low 109.49%
ATR (14) 1.09
Dividend Ex-Date -
Current Ratio 6.69
EPS Y/Y TTM 57.13%
Oper. Margin -2399.50%
RSI (14) 53.99
Volatility 8.91% 7.46%
Employees 16
Debt/Eq 0.01
Sales Y/Y TTM 11011.11%
Profit Margin -1830.60%
Recom 1.00
Target Price 160.00
Option/Short No / Yes
LT Debt/Eq 0.00
EPS Q/Q 73.16%
Payout -
Rel Volume 0.57
Prev Close 16.43
Sales Surprise -
EPS Surprise -
Sales Q/Q -
Earnings Nov 12 AMC
Avg Volume 28.82K
Price 15.46
SMA20 5.42%
SMA50 7.98%
SMA200 -14.64%
Trades
Volume 16,289
Change -5.90%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-19 Initiated
H.C. Wainwright
Buy
Apr-10-18 Downgrade
Stifel
Buy → Hold
$12 → $1
Mar-08-18 Initiated
ROTH Capital
Buy
$17
Feb-08-18 Initiated
Northland Capital
Outperform
$28
Sep-26-16 Initiated
H.C. Wainwright
Buy
$13
Sep-04-15 Initiated
Canaccord Genuity
Buy
$15
Aug-24-15 Initiated
Stifel
Buy
$17
Aug-24-15 Initiated
Piper Jaffray
Overweight
$24
Nov-12-24 05:04PM
(Associated Press Finance) +7.58%
+7.12%
04:05PM
Oct-26-24 05:01PM
Aug-08-24 05:26PM
(Associated Press Finance)
04:15PM
11:23AM
Loading…
Jul-29-24 11:23AM
06:53AM
Jul-26-24 04:05PM
Jun-24-24 04:05PM
May-28-24 08:00AM
May-20-24 12:00PM
May-09-24 10:57PM
05:02PM
(Associated Press Finance)
04:51PM
Mar-19-24 08:30AM
08:24AM
Loading…
Mar-13-24 08:24AM
(Associated Press Finance)
08:00AM
Mar-04-24 03:49PM
08:00AM
Mar-01-24 08:00AM
Feb-28-24 08:00AM
Feb-22-24 04:00PM
Nov-09-23 05:06PM
(Associated Press Finance)
-6.82%
04:30PM
Nov-08-23 08:00AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
Sep-27-23 08:30AM
Sep-26-23 08:30AM
Sep-22-23 05:22AM
08:30AM
Loading…
Sep-18-23 08:30AM
Aug-24-23 12:35PM
Aug-16-23 02:44PM
(American City Business Journals)
Aug-11-23 04:37PM
(Associated Press Finance)
04:30PM
Aug-10-23 08:33AM
Jun-16-23 08:00AM
Jun-15-23 07:33AM
May-24-23 09:00AM
May-12-23 08:11AM
May-11-23 04:33PM
04:15PM
Apr-20-23 08:00AM
Mar-30-23 08:31AM
Mar-17-23 01:01PM
Mar-06-23 06:11PM
05:56PM
08:02AM
Mar-03-23 05:06AM
Feb-27-23 08:02AM
Feb-01-23 05:00PM
Jan-20-23 09:03AM
Jan-09-23 08:00AM
Dec-22-22 06:00AM
Dec-13-22 08:15AM
Dec-03-22 07:04AM
Nov-15-22 02:46PM
(American City Business Journals)
Nov-10-22 06:45PM
05:25PM
Nov-02-22 07:26AM
(American City Business Journals)
Sep-23-22 07:04AM
Aug-19-22 12:42PM
Aug-18-22 06:41AM
(American City Business Journals) -5.43%
Aug-15-22 06:43PM
(GlobeNewswire) +6.20%
-11.68%
Aug-13-22 08:25AM
Aug-09-22 06:09AM
(American City Business Journals)
Jul-27-22 03:01PM
(American City Business Journals)
07:00AM
Jul-25-22 08:22AM
07:00AM
Jun-04-22 11:00AM
Jun-01-22 06:54AM
May-19-22 06:40AM
May-12-22 07:45AM
Mar-31-22 07:34PM
Mar-29-22 09:47PM
Mar-03-22 08:48PM
Jan-13-22 08:30AM
Jan-12-22 05:38PM
Dec-06-21 06:43PM
05:19PM
Dec-03-21 10:00AM
Nov-22-21 06:06AM
(American City Business Journals)
Nov-09-21 09:45AM
08:30AM
Oct-28-21 03:06PM
01:38PM
Oct-20-21 09:00AM
Oct-12-21 07:30AM
Sep-23-21 04:30PM
Sep-13-21 03:40PM
Aug-17-21 10:00AM
Aug-04-21 07:15PM
04:30PM
Jul-27-21 07:50AM
Jun-29-21 07:30AM
Jun-22-21 09:48PM
10:11AM
08:28AM
07:30AM
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SEKHRI PAUL J Pres, CEO and Exec Chairperson Nov 15 '24 Buy 16.65 3,156 52,543 3,156 Nov 19 04:31 PM SEKHRI PAUL J Pres, CEO and Exec Chairperson Nov 18 '24 Buy 16.96 1,844 31,269 5,000 Nov 19 04:31 PM
Index -
P/E 56.22
EPS (ttm) 3.75
Insider Own 8.93%
Shs Outstand 161.26M
Perf Week -9.67%
Market Cap 34.11B
Forward P/E 30.82
EPS next Y 6.83
Insider Trans -0.13%
Shs Float 147.47M
Perf Month -4.06%
Income 615.26M
PEG 2.96
EPS next Q 1.58
Inst Own 79.66%
Short Float 1.63%
Perf Quarter 6.89%
Sales 2.57B
P/S 13.25
EPS this Y 28.89%
Inst Trans 0.81%
Short Ratio 2.55
Perf Half Y 2.37%
Book/sh 32.04
P/B 6.57
EPS next Y 9.56%
ROA 10.65%
Short Interest 2.40M
Perf Year 17.86%
Cash/sh 30.17
P/C 6.98
EPS next 5Y 19.00%
ROE 13.18%
52W Range 165.12 - 240.68
Perf YTD 9.41%
Dividend Est. -
P/FCF 35.11
EPS past 5Y 16.91%
ROI 11.77%
52W High -12.49%
Beta 0.81
Dividend TTM -
Quick Ratio 5.01
Sales past 5Y 22.64%
Gross Margin 73.21%
52W Low 27.56%
ATR (14) 6.15
Dividend Ex-Date -
Current Ratio 5.01
EPS Y/Y TTM 11.50%
Oper. Margin 22.75%
RSI (14) 42.12
Volatility 3.21% 2.59%
Employees 7172
Debt/Eq 0.01
Sales Y/Y TTM 15.29%
Profit Margin 23.91%
Recom 2.00
Target Price 248.92
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 52.05%
Payout 0.00%
Rel Volume 1.28
Prev Close 209.89
Sales Surprise 1.25%
EPS Surprise 5.59%
Sales Q/Q 14.56%
Earnings Dec 05 AMC
Avg Volume 942.54K
Price 210.63
SMA20 -3.62%
SMA50 -1.89%
SMA200 2.19%
Trades
Volume 1,187,607
Change 0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-19-24 Initiated
Scotiabank
Sector Perform
$235
Oct-08-24 Initiated
Exane BNP Paribas
Outperform
$286
Aug-27-24 Reiterated
Citigroup
Buy
$256 → $273
Jul-09-24 Initiated
BTIG Research
Buy
$240
Oct-25-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$211 → $229
Oct-13-23 Initiated
Jefferies
Buy
$265
Jun-28-23 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$181
Jun-01-23 Upgrade
Guggenheim
Neutral → Buy
$226
Mar-17-23 Downgrade
Truist
Buy → Hold
$205 → $195
Feb-23-23 Downgrade
Guggenheim
Buy → Neutral
Jan-04-23 Upgrade
Barclays
Equal Weight → Overweight
$205
Dec-06-22 Initiated
Cowen
Market Perform
$184
Dec-02-22 Reiterated
Needham
Buy
$205 → $220
Oct-31-22 Initiated
Wells Fargo
Equal Weight
$180
Oct-19-22 Upgrade
JP Morgan
Underweight → Neutral
$225 → $170
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$220
Jul-27-22 Initiated
Oppenheimer
Outperform
$250
Jun-23-22 Initiated
Goldman
Buy
$253
Jun-21-22 Resumed
Guggenheim
Buy
$252
Mar-03-22 Downgrade
BofA Securities
Buy → Neutral
$300 → $220
Show Previous Ratings
Today 07:03AM
04:30AM
Nov-20-24 04:00AM
Nov-19-24 07:03AM
Nov-18-24 05:45PM
08:00PM
Loading…
Nov-17-24 08:00PM
Nov-14-24 04:14PM
10:03AM
09:00AM
07:03AM
Nov-12-24 09:30AM
Nov-11-24 05:45PM
04:03AM
Nov-08-24 08:37AM
(Morningstar Research) +5.20%
Nov-04-24 06:30AM
05:45PM
Loading…
Nov-01-24 05:45PM
Oct-31-24 09:00AM
Oct-29-24 07:03AM
Oct-25-24 05:45PM
Oct-24-24 08:00AM
Oct-23-24 05:50PM
Oct-21-24 09:30AM
Oct-20-24 03:42PM
Oct-17-24 05:50PM
09:00AM
04:41AM
Oct-15-24 04:30PM
Oct-14-24 04:59AM
Oct-13-24 10:28AM
Oct-11-24 12:32PM
05:50PM
Loading…
Oct-10-24 05:50PM
Oct-03-24 09:00AM
06:45AM
Oct-02-24 07:03AM
Sep-27-24 11:30AM
Sep-24-24 07:03AM
Sep-23-24 09:50AM
09:35AM
Sep-18-24 09:00AM
Sep-14-24 02:51PM
Sep-11-24 08:46AM
07:00AM
Sep-09-24 05:04PM
Sep-08-24 08:00PM
Sep-06-24 04:08AM
Sep-05-24 09:50AM
09:15AM
09:00AM
07:45AM
07:03AM
Sep-04-24 09:00PM
Sep-03-24 09:00PM
Aug-30-24 01:45PM
Aug-29-24 01:33PM
12:51PM
08:31AM
Aug-28-24 11:45PM
06:00PM
05:20PM
04:29PM
04:18PM
(Associated Press Finance)
04:05PM
Aug-27-24 07:03AM
03:02AM
Aug-23-24 09:15AM
Aug-22-24 09:00AM
07:03AM
Aug-21-24 09:30AM
Aug-20-24 09:00PM
Aug-19-24 05:45PM
07:31AM
Aug-14-24 09:53AM
Aug-13-24 07:03AM
Aug-12-24 05:55PM
Aug-07-24 04:15PM
Aug-05-24 05:45PM
Aug-01-24 09:00AM
Jul-30-24 05:45PM
Jul-25-24 09:03AM
07:03AM
Jul-24-24 05:45PM
12:02PM
Jul-23-24 09:30AM
Jul-18-24 05:50PM
09:50AM
08:28AM
Jul-16-24 09:45AM
Jul-15-24 10:20AM
Jul-14-24 07:00AM
Jul-12-24 05:50PM
Jul-09-24 07:59AM
Jul-03-24 10:45AM
10:23AM
Jun-28-24 09:45AM
Jun-26-24 09:45AM
Jun-25-24 10:25AM
Jun-24-24 07:09AM
Jun-20-24 12:07PM
06:32AM
06:24AM
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Schwenger Thomas D. Pres. & Chief Customer Officer Nov 08 '24 Sale 240.01 1,126 270,252 27,013 Nov 12 10:48 AM Schwenger Thomas D. Director Nov 08 '24 Proposed Sale 240.01 1,126 270,252 Nov 08 12:28 PM Zuppas Eleni Nitsa President & Chief of Staff Oct 01 '24 Option Exercise 0.00 1,324 0 22,645 Oct 02 05:58 PM Schwenger Thomas D. Pres. & Chief Customer Officer Oct 01 '24 Option Exercise 0.00 1,909 0 28,974 Oct 02 05:55 PM DIAMOND KRISTINE Chief Accounting Officer Oct 01 '24 Option Exercise 0.00 204 0 692 Oct 02 05:54 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Oct 01 '24 Option Exercise 0.00 1,120 0 10,155 Oct 02 05:53 PM Cabral Timothy S Interim CFO Sep 01 '24 Option Exercise 0.00 315 0 1,426 Sep 03 05:56 PM Carges Mark T Director Sep 01 '24 Option Exercise 0.00 357 0 357 Sep 03 05:00 PM Hedley Mary Lynne Director Sep 01 '24 Option Exercise 0.00 343 0 5,075 Sep 03 04:57 PM Hung Priscilla Director Sep 01 '24 Option Exercise 0.00 343 0 3,281 Sep 03 04:56 PM Hunt Nimrata Director Sep 01 '24 Option Exercise 0.00 343 0 3,174 Sep 03 04:55 PM MOHR MARSHALL Director Sep 01 '24 Option Exercise 0.00 385 0 3,667 Sep 03 04:53 PM Ritter Gordon Director Sep 01 '24 Option Exercise 0.00 399 0 1,102 Sep 03 04:52 PM SEKHRI PAUL J Director Sep 01 '24 Option Exercise 0.00 329 0 15,683 Sep 03 04:51 PM Wallach Matthew J Director Sep 01 '24 Option Exercise 0.00 329 0 104,934 Sep 03 04:49 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Aug 21 '24 Sale 200.00 2,353 470,600 9,035 Aug 21 05:10 PM Faddis Jonathan Officer Aug 21 '24 Proposed Sale 200.00 2,353 470,600 Aug 21 04:27 PM Epstein Stacey Chief Marketing Officer Jul 01 '24 Option Exercise 0.00 891 0 891 Jul 02 05:21 PM Zuppas Eleni Nitsa President & Chief of Staff Jul 01 '24 Option Exercise 0.00 1,324 0 21,321 Jul 02 05:21 PM Schwenger Thomas D. Pres. & Chief Customer Officer Jul 01 '24 Option Exercise 0.00 1,909 0 27,867 Jul 02 05:21 PM DIAMOND KRISTINE Chief Accounting Officer Jul 01 '24 Option Exercise 0.00 204 0 561 Jul 02 05:21 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Jul 01 '24 Option Exercise 0.00 1,120 0 11,788 Jul 02 05:21 PM Cabral Timothy S Interim CFO Jun 07 '24 Sale 184.33 15,000 2,764,931 8,391 Jun 07 05:53 PM Hung Priscilla Director Jun 01 '24 Option Exercise 0.00 302 0 2,938 Jun 03 05:12 PM Cabral Timothy S Director Jun 01 '24 Option Exercise 0.00 278 0 1,111 Jun 03 05:11 PM Carges Mark T Director Jun 01 '24 Option Exercise 0.00 315 0 315 Jun 03 05:10 PM Hedley Mary Lynne Director Jun 01 '24 Option Exercise 0.00 302 0 4,732 Jun 03 05:09 PM Hunt Nimrata Director Jun 01 '24 Option Exercise 0.00 302 0 2,831 Jun 03 05:09 PM MOHR MARSHALL Director Jun 01 '24 Option Exercise 0.00 339 0 3,282 Jun 03 05:08 PM Ritter Gordon Director Jun 01 '24 Option Exercise 0.00 352 0 703 Jun 03 05:08 PM SEKHRI PAUL J Director Jun 01 '24 Option Exercise 0.00 290 0 15,354 Jun 03 05:07 PM Wallach Matthew J Director Jun 01 '24 Option Exercise 0.00 290 0 104,605 Jun 03 05:06 PM MATEO ALAN EVP Global Sales Apr 23 '24 Sale 200.86 3,391 681,116 21,983 Apr 23 07:09 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Apr 15 '24 Sale 207.42 3,598 746,297 10,668 Apr 16 04:33 PM Schwenger Thomas D. President and COO Apr 01 '24 Option Exercise 0.00 2,268 0 26,610 Apr 02 03:51 PM Zuppas Eleni Nitsa Chief Marketing Officer Apr 01 '24 Option Exercise 0.00 1,620 0 20,677 Apr 02 03:49 PM MATEO ALAN EVP Global Sales Apr 01 '24 Option Exercise 0.00 6,944 0 26,983 Apr 02 03:47 PM DIAMOND KRISTINE Chief Accounting Officer Apr 01 '24 Option Exercise 0.00 220 0 435 Apr 02 03:44 PM Bowman Brent R Former Chief Financial Officer Apr 01 '24 Option Exercise 0.00 1,296 0 9,287 Apr 02 03:43 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Apr 01 '24 Option Exercise 0.00 1,296 0 19,729 Apr 02 03:41 PM Cabral Timothy S Director Mar 07 '24 Sale 226.04 15,000 3,390,657 23,391 Mar 07 05:35 PM Cabral Timothy S Director Mar 01 '24 Option Exercise 0.00 277 0 833 Mar 05 02:29 PM Hung Priscilla Director Mar 01 '24 Option Exercise 0.00 302 0 2,636 Mar 05 02:27 PM Hunt Nimrata Director Mar 01 '24 Option Exercise 0.00 302 0 2,529 Mar 05 02:27 PM MOHR MARSHALL Director Mar 01 '24 Option Exercise 0.00 339 0 2,943 Mar 05 02:26 PM Ritter Gordon Director Mar 01 '24 Option Exercise 0.00 351 0 351 Mar 05 02:25 PM SEKHRI PAUL J Director Mar 01 '24 Option Exercise 0.00 290 0 15,064 Mar 05 02:24 PM Wallach Matthew J Director Mar 01 '24 Option Exercise 0.00 290 0 104,315 Mar 05 02:24 PM Carges Mark T Director Mar 01 '24 Option Exercise 0.00 314 0 314 Mar 05 02:23 PM Hedley Mary Lynne Director Mar 01 '24 Option Exercise 0.00 302 0 4,430 Mar 05 02:22 PM Wallach Matthew J Director Feb 05 '24 Sale 203.43 5,000 1,017,147 104,025 Feb 06 08:02 PM Schwenger Thomas D. President and COO Jan 22 '24 Sale 210.02 1,238 260,001 24,342 Jan 24 01:59 PM MATEO ALAN EVP Global Sales Jan 17 '24 Sale 204.72 910 186,295 21,983 Jan 18 11:48 AM Zuppas Eleni Nitsa Chief Marketing Officer Jan 12 '24 Option Exercise 135.49 3,000 406,470 22,057 Jan 12 07:37 PM Zuppas Eleni Nitsa Chief Marketing Officer Jan 12 '24 Sale 204.75 3,000 614,250 19,057 Jan 12 07:37 PM Zuppas Eleni Nitsa Chief Marketing Officer Jan 09 '24 Option Exercise 135.49 4,350 589,382 23,407 Jan 11 07:10 PM Zuppas Eleni Nitsa Chief Marketing Officer Jan 09 '24 Sale 192.61 4,350 837,860 19,057 Jan 11 07:10 PM Wallach Matthew J Director Jan 05 '24 Sale 186.05 5,000 930,238 109,025 Jan 08 01:16 PM DIAMOND KRISTINE Chief Accounting Officer Jan 01 '24 Option Exercise 0.00 365 0 365 Jan 03 01:23 PM Zuppas Eleni Nitsa Chief Marketing Officer Jan 01 '24 Option Exercise 0.00 1,619 0 19,680 Jan 03 01:23 PM Schwenger Thomas D. President and COO Jan 01 '24 Option Exercise 0.00 2,267 0 26,277 Jan 03 01:22 PM MATEO ALAN EVP Global Sales Jan 01 '24 Option Exercise 0.00 1,943 0 23,926 Jan 03 01:21 PM Faddis Jonathan SVP, Gen. Counsel, Secretary Jan 01 '24 Option Exercise 0.00 1,295 0 18,941 Jan 03 01:21 PM Bowman Brent R Chief Financial Officer Jan 01 '24 Option Exercise 0.00 1,295 0 8,499 Jan 03 01:20 PM Hedley Mary Lynne Director Dec 28 '23 Sale 191.07 42 8,025 4,128 Dec 28 05:24 PM Hedley Mary Lynne Director Dec 27 '23 Sale 190.96 41 7,829 4,170 Dec 28 05:24 PM MATEO ALAN EVP Global Sales Dec 22 '23 Option Exercise 26.99 6,280 169,497 28,263 Dec 22 07:58 PM MATEO ALAN EVP Global Sales Dec 22 '23 Sale 190.00 6,280 1,193,200 21,983 Dec 22 07:58 PM Cabral Timothy S Director Dec 14 '23 Sale 181.44 5,000 907,189 38,391 Dec 14 03:09 PM Cabral Timothy S Director Dec 07 '23 Sale 168.74 10,000 1,687,358 43,391 Dec 08 01:13 PM Wallach Matthew J Director Dec 04 '23 Sale 179.15 5,000 895,731 114,025 Dec 05 12:37 PM Cabral Timothy S Director Dec 01 '23 Option Exercise 0.00 278 0 556 Dec 04 12:52 PM Carges Mark T Director Dec 01 '23 Option Exercise 0.00 315 0 315 Dec 01 07:04 PM Hedley Mary Lynne Director Dec 01 '23 Option Exercise 0.00 303 0 4,211 Dec 01 07:01 PM Hung Priscilla Director Dec 01 '23 Option Exercise 0.00 303 0 2,334 Dec 01 07:00 PM Hunt Nimrata Director Dec 01 '23 Option Exercise 0.00 303 0 2,227 Dec 01 06:53 PM MOHR MARSHALL Director Dec 01 '23 Option Exercise 0.00 340 0 2,604 Dec 01 06:50 PM Ritter Gordon Director Dec 01 '23 Option Exercise 0.00 352 0 1,001,463 Dec 01 06:47 PM SEKHRI PAUL J Director Dec 01 '23 Option Exercise 0.00 290 0 14,774 Dec 01 06:41 PM Wallach Matthew J Director Dec 01 '23 Option Exercise 0.00 290 0 119,025 Dec 01 06:38 PM MATEO ALAN EVP Global Sales Nov 28 '23 Option Exercise 135.49 2,214 299,975 21,983 Nov 29 01:36 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite